Safety Rates Drug Report: NOVOLOG Glycosylated haemoglobin increased adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: NOVOLOG Injury: Glycosylated haemoglobin increased Quarter: 2016Q3

|< 1/2 << Previous Page Page 2

Total Records: 21 Number of Pages: 2

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
127668261	NOVOLOG	Glycosylated haemoglobin increased	NOVO NORDISK	52.00 YR	F	0	20160921	US

|< 1/2 << Previous Page Page 2

Total Records: 21 Number of Pages: 2

Execution Time: 0.11053800582886 seconds (ucode:5154666). Developed by: James D. Barger